[Official Trailer] Special Episode (PART 3) - Conversation with KOL Hepatologists and Pharma Thought Leaders in NASH Dialogues on AI Digital Pathology

Our Special Episode conversation on AI Digital Pathology in NASH Drug Development continues (in Parts 3 and 4) with our guests, KOL hepatologists and Pharma Thought Leaders in NASH, as they respond to questions by Pharma companies and clinical investigators on how AI Digital Pathology (AI-DP) can augment clinical trial data and work alongside pathologists to detect granular information that could be pivotal for determining patient recruitment, staging and treatment responses. The full Part 3 podcast will be launched early next week, so click here to listen to the Trailer of Part 3!

A huge Thank You to our Guests and Moderator for their kind participation and professional views spoken in this entire Special Episode!

Guests

Prof. Stephen Harrison, Medical Director, Pinnacle Clinical Research

Prof. Vlad Ratziu, Professor of Hepatology, Sorbonne University and Pitié-Salpêtrière Hospital

Dr. Judith Ertle, Senior Clinical Program Lead NASH, Boehringer Ingelheim

Dr. Karin Conde-Knape, ‎Senior Vice President Global Drug Discovery, Novo Nordisk

Ms. Kitty Yale, EVP and Chief Development Officer, Akero Therapeutics



Moderator

Dr. Nikolai Naoumov, Senior Adviser, Clinical Research and Drug Development in Liver Diseases, Novartis



Do remember to Subscribe to our Podcast to receive updates on new episodes!